Synthesis of some novel Carbazole derivatives and evaluation of their antimicrobial activity

Abstract

Keywords

• -

Bazı yeni karbazol türevlerinin sentezleri ve antimikrobiyal aktivitelerinin araştılılması

Abstract

Karbazol ve türevleri, antimikrobiyal aktiviteleri nedeniyle medisinal kimyacıların ilgisini çeken azotlu heterosiklik bileşiklerdir. Bu amaçla yeni karbazol türevleri sentezlendi ve antimikrobiyal aktiviteleri araştırıldı. Başlangıç maddesi olarak 2-kloro-N-(9-etil-9H-karbazol-3-il)asetamid, 3-amino-9-etil-9H-karbazol ile kloroasetil klorürün reaksiyonuyla hazırlandı. 2-Kloro-N-(9-etil-9H-karbazol-3-il)asetamid ile merkapto-heterosikliklerin reaksiyonu ile sonuç bileşikleri elde edildi. Bileşiklerin kimyasal yapıları IR, 1H-NMR, FAB-MS spektroskopik verileri ve elemental analiz ile aydınlatıldı. Bileşiklerin antimikrobiyal aktiviteleri Candida albicans (iki suş), Candida glabrata, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa’a karşı araştırıldı

Keywords

• Karbazol, antimikrobiyal aktivite

References

1. Tenover FC, McDonald LC. Vancomycin-resistant sta- phylococci and enterococci: epidemiology and control. Curr Opin Infect Dis 2005; 18: 300-305.
2. Pfeltz RF, Wilkinson BJ. The escalating challenge of van- comycin resistance in Staphylococcus aureus. Curr Drug Targets Infect Disord 2004; 4: 273-294.
3. Roberts MC. Distribution of Macrolide, Lincosamide, Streptogramin, Ketolide and Oxazolidinone (MLSKO) Resistance Genes in Gram-negative Bacteria. Curr Drug Targets Infect Disord 2004; 4(3): 207-215.
4. McDonald LC. Trends in Antimicrobial Resistance in Health Care-Associated Pathogens and Effect on Treat- ment. Clin Infect Dis 2006; 42: 65-71.
5. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73–85.
6. Cuenca-Estrella M, Rodriguez-Tudela JL. Present status of the detection of antifungal resistance: the perspective from both sides of the ocean. Clin Microbiol Infect 2001; 7(2): 46-53.
7. Poeta D, Schell WA, Dykstra CC, Jones SK, Tidwell RR, Kumar A, Boykin DW, Perfect JR. In Vitro Antifungal Activities of a Series of Dication-Substituted Carbazoles, Furans, and Benzimidazoles. Antimicrob Agents Ch 1998; 42(10): 2503-2510.
8. Silverman RB. Organic Chemistry of Drug Design and Drug Action, Academic Press, San Diego, 1992.

9. Zhang FF, Gan LL, Cheng-He Zho CH. Synthesis, anti- bacterial and antifungal activities of some carbazole de- rivatives. Bioorg Med Chem Lett 2010; 20(6): 1881-1884.
10. Knolker HJ, Reddy KR. Isolation and synthesis of biolog- ically active carbazole alkaloids. Chem Rev 2002; 102(11): 4303-4427.
11. Knolker HJ; Frohner W, Reddy KR. Iron-mediated syn- thesis of carbazomycin G and carbazomycin H, the first carbazole-1,4-quinol alkaloids from Streptoverticillium ehimense. Eur J Org Chem 2003; 4: 740-746.
12. Hagiwara H, Choshi T, Fujimoto H, Sugino E, Hibino SA. Novel Total Synthesis of Antibiotic Carbazole Al- kaloid Carbazomycin G. Tetrahedron 2000; 56(32): 5807- 5811.
13. Cuong NM, Wilhelm H, Porzel A, Arnold N, Wessjo- hann L. 1-O-Substituted derivatives of murrayafoline A and their antifungal properties. Nat Prod Res 2008; 22(16): 1428-1432.
14. Jungheim LN, Sigmund SK, Fisher JW. Bicyclic pyrazo- lidinones, a new class of antibacterial agent based on the β-lactam model. Tetrahedron Lett 1987; 28(3): 285-288.
15. Jungheim LN, Sigmund SK, Jones ND, Swartz-Endruber JK. Bicyclic pyrazolidinones, steric and electronic effects on antibacterial activity. Tetrahedron Lett 1987; 28(3): 289-292.
16. Canuto MM, Rodero GF. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002; 2(9): 550- 563.
17. Elnima EI, Zubair MU, Al-Badr AA. Antibacterial and Antifungal Activities of Benzimidazole and Benzoxazole Derivatives. Antimicrob Agents Ch 1981; 19(1): 29-32.
18. Gupta RR, Kumar M, Gupta V. In Heterocyclic Chem- istry of Five membered Heterocycles. Springer-Verlag Berlin, Heidelber, New York, 1999.
19. Ashtekar DR, Fernandes F, Khadse BG, Shirodkar MVA. A rapid method for the evaluation of new antituberculo- sis agents. Chemotherapy 1987; 33: 22-27.
20. Maass G, Immendoerfer U, Koenig B, Leser U, Mueller B, Goody R, Pfatt B. Viral resistance to the thiazolo-iso- indolinones, a new class of nonnucleoside inhibitors of HIV virus type 1 reverse transcriptase. Antimicrob Agents Ch 1993; 37; 2612-2617.
21. Torrens A, Mas J, Port A, Castrillo JA, Sanfeliu O, Guitart X, Dordal A, Romero A, Fisas MA, Sanchez E, Hernan- dez E, Perez P, Perez R, Buschmann H. Synthesis of New Benzoxazinone Derivatives as Neuropeptide Y5 Antago- nists for the Treatment of Obesity. J Med Chem 2005; 48: 2080-2092.
22. Koneman EW, Allen SD, Winn WC. Colour Atlas and Textbook of Diagnostic Microbiology. Lippincott Raven Publishers, Philadelphia, 1997.
23. NCCLS, Reference Method for Broth Dilution Antifun- gal Susceptibility Testing of Yeasts; (2002), Approved Standard, second ed., NCCLS document M27-A2 [ISBN 1-56238-469-4].